INS and type 2 diabetes mellitus: Alternatively, the mutation may be associated with specific T2D-related phenotypes not measured in our sample [glucose/insulin OGTT-and clamp-based insulin sensitivity/beta-cell function indexes, repeated glycemia measurements during the night and the day, or biomarkers (e.g., serum level of GLP-1)].